In Vitro Antifungal Activity of Saperconazole (R 66905) Against Candida and Torulopsis Die antimyzetische Aktivität von Saperconazol (R 66905) in vitro gegen Candida und Torulopsis-Reference-Cited by-同舟云学术

In Vitro Antifungal Activity of Saperconazole (R 66905) Against Candida and Torulopsis Die antimyzetische Aktivität von Saperconazol (R 66905) in vitro gegen Candida und Torulopsis

Published:2009-04-24 Issue:12 Volume:32 Page:631-637
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:

Author:

Mallié M.,Montès B.,Lebecq J.C.,Bastide J.M.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1439-0507.1989.tb02195.x/fullpdf

Reference15 articles.

1. Activité in vitro de I'itraconazole sur diverses espèces de Candida;Bastide;Path. Biol.,1989

2. Evaluation de l'activité in vitro des antifongiques;Bastide;Le Biologiste,1989

3. Action du kétoconazole in vitro et in vivo dans les mycoses expénmentales, taux sériques chez l'homme;Drouhet;Bull. Soc. Fr. Mycol. Med.,1979

4. Overview of medically important antifungal azole derivatives;Fromtling;Clin. Microbiol. Rev.,1988

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphological changes of Candida, albicans induced by saperconazole;Mycoses;2009-04-24

2. Clinical efficacy and tolerability of saperconazole for tinea of glabrous skin. A report on four cases;Mycoses;2009-04-24

3. Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development;Advances in Pharmacology;1998

4. Saperconazole therapy of murine disseminated candidiasis: efficacy and interactions with amphotericin B;Antimicrobial Agents and Chemotherapy;1994-02

5. Susceptibility of clinical isolates of fungi to saperconazole;Mycopathologia;1992-06